Explore Stanford technologies available for licensing:

Inventors at Stanford have developed a novel strategy to perform concurrent fluorescence measurements of multiple biological parameters in freely moving and head-restrained animals.

Researchers at Stanford have found that applying pressure to macroencapsulation can enhance insulin transport from encapsulated islet beta cells to surrounding tissue and assist in glucose metabolism in type 1 diabetes (T1D) patients.

Stanford researchers have identified an appropriate method and dosage for radiotherapy-based noninvasive lung volume reduction to treat severe emphysema.

Researchers at Stanford have developed a novel method for the mapping of nucleic acid binding or modifying proteins in a massively multiplexed manner.

Stanford researchers have developed a method for manufacturing high quality multifunctional soft electronic fibers based on conventional microfabrication techniques.

Stanford researchers at the Zhao Lab have designed milli-spinner thrombectomy devices that mechanically debulk clots by safely shredding the clots for fast and complete clot removal.

Stanford researchers in the Zhao Lab have developed a mechanical thrombectomy device for Pulmonary Embolism (PE) that mechanically debulks and reduces volume of large clots without causing fragmentation.

Stanford researchers have developed easyBAT, a simplified solution integrating a microfluidic sample preparation device with a fully automated analysis pipeline for rapid, accurate and accessible solution for food allergy diagnosis at the point-of-care.

Stanford researchers in the Noh Lab have developed a non-intrusive, scalable approach to gait analysis.

Stanford scientists have developed a novel hydrogel for long-term drug delivery of an Activator Protein 1 (AP-1) inhibitor for the prevention of post-surgical abdominal adhesion.

Stanford researchers have designed a tunable matching network that is compact, fast, low-cost, robust, and simple to control.

The Longaker lab at Stanford University has developed a machine learning algorithm that can analyze and detect fibrotic disease.

The Longaker lab at Stanford University has recently discovered that local injection of the drug Verteporfin after wounding can reduce scarring, improve the strength of healed skin, and regrow the hair follicles and sweat glands that are usually lost during the scarring proces

Inventors at Stanford University have developed a light-based 3D printing system that achieves high printing resolutions and fast printing speeds with cell-compatible natural protein biomaterials when compared to existing methods.

Skin wounds invariably heal by developing fibrotic scar tissue, which can result in devastating disfigurement, growth restriction and permanent functional loss.